UCSF Archives | Be Korea-savvy

Home / Posts tagged UCSF

Understanding the Evolution of SARS-CoV-2 Could Be the Key to Treating It, According to Researchers at the UCSF QBI Coronavirus Research Group (QCRG)

SAN FRANCISCO, Oct. 25 (Korea Bizwire) — Researchers at the UCSF QBI Coronavirus Research Group (QCRG) have uncovered how the SARS-CoV-2 variants of concern (VOC) differ in their ability to manipulate human cells on a molecular level during infection. They have discovered variant specific differences in viral RNA and protein levels, including viral proteins N, Orf6, and [...]

University of California, San Francisco Joins Forces with Philips to Enhance the Digital Patient Experience with Philips HealthSuite

Amsterdam, the Netherlands and San Francisco, CA, May 26 (Korea Bizwire) – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and the University of California, San Francisco (UCSF), a world-class biomedical research hub and health system, today announced a partnership to develop technology that will enable a modern, more streamlined experience for patients and set a new standard for [...]

Cell Publication Elucidates How SARS-CoV-2 Dramatically Rewires Important Cell Programming; Identifies Existing Therapeutics That May Fight COVID-19

SAN FRANCISCO, June 28 (Korea Bizwire) — Pioneering a new paradigm in drug discovery by leveraging biological understanding of how a virus interacts with its host, an international team of researchers conducted a global analysis of proteins in human cells to determine mechanisms by which SARS-CoV-2 shifts cellular activity in infected cells. During the study, [...]

Nature Publication Highlights New ‘Blueprint’ Revealing How SARS-CoV-2 Hijacks Human Cells; Points to Drugs with Potential to Fight COVID-19 and a Drug That Aids Its Infectious Growth

SAN FRANCISCO, Calif., April 30 (Korea Bizwire) — An international team of more than 120 scientists has detailed the impact of 75 over-the-counter prescription and development-stage drug compounds on SARS-CoV-2, the virus that causes COVID-19. Several of these agents show promise in blocking SARS-CoV-2 replication in laboratory experiments. One compound investigated in the research, a [...]